4. Disturbed sleep pattern related to side effects of overstimula-● 6. Pain related to side effect of abdominal pain (atomoxetine, Extended release tabs: 5. Nausea related to side effects of atomoxetine or bupropion. 7. Risk for activity intolerance related to side effects of sedation 3. Imbalanced nutrition, less than body requirements, related Seasonal Affective Disorder (Wellbutrin XL): 2. Risk for suicide secondary to major depression related to 1. Risk for injury related to overstimulation and hyperac-^534 the onset of depressive symptoms. Dose may be uptitrated to the target dose of 300 mg/day after 1 week. Therapy should continue through the winter season before being tapered to 150 mg/day for 2 weeks prior to discontinuation in early spring. single daily dose in the morning. May increase after 3 days to administered each morning beginning in the autumn prior to 300 mg/day, given as a single daily dose in the morning.^ bupropion).TO AGENTS FOR ADHDtion or insomnia.or dizziness (atomoxetine or bupropion) tivity (CNS stimulants) or seizures (possible side effect of bupropion) or headache (all agents).to side effects of anorexia and weight loss (CNS stimulants).abrupt withdrawal after extended use (CNS stimulants).NURSING DIAGNOSES RELATED^ ●^ PSYCHOTROPIC MEDICATIONS Begin dosing at 150 mg/day, given as a^ PO: 150 mg
2 2506_Ch31_522-537.indd 1534 506 Ch 31 522 - 537 .ind 1. The plan of care should include monitoring for the follow-ing side effects from agents for ADHD. Nursing implications 2. related to each side effect are designated by an asterisk ().● d 1 bupropion; clonidine) or Overstimulation, restlessness, insomnia *^ NURSING IMPLICATIONS FOR ADHD Palpitations, tachycardia AGENTS* 5 Ensure that the client is protected from injury. Assess mental status for changes in mood, level of activity, Keep stimuli low and environment as quiet as possible to 3 To prevent insomnia, administer the last dose at least Monitor and record vital signs at regular intervals (two or 4 discourage overstimulation.forms in the morning.changes to the physician immediately.three times a day) throughout therapy. Report signifidegree of stimulation, and aggressiveness.6 hours before bedtime. Administer sustained-release bradycardia(CNS stimulants; atomoxetine; (clonidine, guanfacine)(CNS stimulants) cant 1 10/1/10 9:40:58 AM 0 / 1 / 10 9 : 40 : 58 AM
